{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:15:03Z","timestamp":1790964903321,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.hfc.2020.12.002","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T08:23:24Z","timestamp":1611908604000},"page":"195-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Anemia and Management of Heart Failure Patients"],"prefix":"10.1016","volume":"17","author":[{"given":"Carmen C.","family":"Beladan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona B.","family":"Botezatu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2020.12.002_bib1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hfc.2020.12.002_bib2","series-title":"Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity","author":"WHO","year":"2011"},{"key":"10.1016\/j.hfc.2020.12.002_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.CIR.0000052622.51963.FC","article-title":"Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure","volume":"107","author":"Ezekowitz","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2020.12.002_bib4","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/CIRCULATIONAHA.105.582577","article-title":"Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program","volume":"113","author":"O'Meara","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2020.12.002_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijcard.2003.04.073","article-title":"Prevalence of anemia in patients admitted to hospital with a primary diagnosis of congestive heart failure","volume":"96","author":"Wexler","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2020.12.002_bib6","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2008.04.061","article-title":"Anemia and mortality in heart failure patients a systematic review and meta-analysis","volume":"52","author":"Groenveld","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2020.12.002_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijcard.2019.08.049","article-title":"Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum [published correction appears in Int J Cardiol 2020 Jan 20]","volume":"298","author":"Savarese","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2020.12.002_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","article-title":"Anemia and iron deficiency in heart failure: current concepts and emerging therapies","volume":"138","author":"Anand","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2020.12.002_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jchf.2017.08.023","article-title":"Anemia in heart failure: still relevant?","volume":"6","author":"Grote Beverborg","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hfc.2020.12.002_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/HCO.0000000000000714","article-title":"Iron deficiency in heart failure: getting to the guidelines","volume":"35","author":"Lavoie","year":"2020","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.hfc.2020.12.002_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000496822","article-title":"Management of iron deficiency in heart failure","volume":"142","author":"Zusman","year":"2019","journal-title":"Acta Haematol"},{"key":"10.1016\/j.hfc.2020.12.002_bib12","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure [published correction appears in Eur Heart J 2011:32:1054]","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2020.12.002_bib13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00392-016-1073-y","article-title":"Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: the PrEP registry","volume":"106","author":"von Haehling","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.hfc.2020.12.002_bib14","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1093\/eurheartj\/ehz680","article-title":"Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use","volume":"40","author":"van der Wal","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2020.12.002_bib15","first-page":"52","article-title":"Anemia in heart failure - from guidelines to controversies and challenges","volume":"20","author":"S\u00eerbu","year":"2018","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.hfc.2020.12.002_bib16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.117.030816","article-title":"Heart failure stimulates tumor growth by circulating factors","volume":"138","author":"Meijers","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2020.12.002_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11897-017-0337-9","article-title":"Inflammation - cause or consequence of heart failure or both?","volume":"14","author":"Van Linthout","year":"2017","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.hfc.2020.12.002_bib18","doi-asserted-by":"crossref","first-page":"14056","DOI":"10.3390\/ijms160614056","article-title":"Is correction of iron deficiency a new addition to the treatment of the heart failure?","volume":"16","author":"Silverberg","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hfc.2020.12.002_bib19","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/eurheartj\/ehs377","article-title":"Iron status in patients with chronic heart failure","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2020.12.002_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000342110","article-title":"Anemia in heart failure: association of hepcidin levels to iron deficiency in stable outpatients","volume":"129","author":"Weber","year":"2013","journal-title":"Acta Haematol"},{"key":"10.1016\/j.hfc.2020.12.002_bib21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ehjcvp\/pvu016","article-title":"Iron deficiency in patients with heart failure","volume":"1","author":"Fitzsimons","year":"2015","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.hfc.2020.12.002_bib22","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2020.12.002_bib23","doi-asserted-by":"crossref","first-page":"671-vi","DOI":"10.1016\/j.hoc.2014.04.005","article-title":"Anemia of inflammation","volume":"28","author":"Nemeth","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.hfc.2020.12.002_bib24","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/CIRCULATIONAHA.105.583666","article-title":"Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options","volume":"113","author":"Tang","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2020.12.002_bib25","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1157\/13108999","article-title":"Anemia en la insuficiencia cardiaca: fisiopatolog\u00eda, patogenia, tratamiento e inc\u00f3gnitas [Anemia in heart failure: pathophysiology, pathogenesis, treatment, and incognitae]","volume":"60","author":"Caramelo","year":"2007","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.hfc.2020.12.002_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ncpneph0655","article-title":"Mechanisms of disease: erythropoietin resistance in patients with both heart and kidney failure","volume":"4","author":"van der Putten","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.hfc.2020.12.002_bib27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2004.10.038","article-title":"Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction","volume":"45","author":"Ishani","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2020.12.002_bib28","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/CIRCULATIONAHA.104.512988","article-title":"Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT","volume":"112","author":"Anand","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2020.12.002_bib29","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/ndt\/14.8.1836","article-title":"The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetin","volume":"14","author":"Macdougall","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.hfc.2020.12.002_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1826186807003001-201","article-title":"Anemia and heart failure: a cause of progression or only a consequence?","volume":"3","author":"Metra","year":"2007","journal-title":"Heart Int"},{"key":"10.1016\/j.hfc.2020.12.002_bib31","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/eurheartj\/ehl012","article-title":"The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET","volume":"27","author":"Komajda","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2020.12.002_bib32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10741-008-9088-8","article-title":"Heart failure and anemia: mechanisms and pathophysiology","volume":"13","author":"Anand","year":"2008","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.hfc.2020.12.002_bib33","doi-asserted-by":"crossref","unstructured":"Locatelli F, Pozzoni P, Del Vecchio L, et al. Effect of anemia on left ventricular hypertrophy in end-stage renal disease. The European Journal of Heart Failure Supplements 2003;Volume 2, Issue S2.p.207\u2013212. Available at: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1016\/S1567-4215%2803%2980004-8.","DOI":"10.1016\/S1567-4215(03)80004-8"},{"key":"10.1016\/j.hfc.2020.12.002_bib34","first-page":"340","article-title":"The cardiomyopathy of iron deficiency","volume":"33","author":"Hegde","year":"2006","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.hfc.2020.12.002_bib35","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/BF00180283","article-title":"Cardiac involvement during and after malaria","volume":"70","author":"Franzen","year":"1992","journal-title":"Clin Investig"},{"key":"10.1016\/j.hfc.2020.12.002_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.CIR.0000134279.79571.73","article-title":"Anemia and its relationship to clinical outcome in heart failure","volume":"110","author":"Anand","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2020.12.002_bib37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.amjcard.2007.07.067","article-title":"Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry)","volume":"101","author":"Young","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2020.12.002_bib38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/qjmed\/hcv087","article-title":"Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis","volume":"109","author":"Berry","year":"2016","journal-title":"QJM"},{"key":"10.1016\/j.hfc.2020.12.002_bib39","article-title":"Association between anemia and outcome in patients hospitalized for acute heart failure syndromes: findings from Beijing acute heart failure registry (Beijing AHF Registry)","author":"Ye","year":"2020","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.hfc.2020.12.002_bib40","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/eurjhf\/hfr044","article-title":"Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study","volume":"13","author":"von Haehling","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hfc.2020.12.002_bib41","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.amjcard.2014.09.024","article-title":"Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance)","volume":"114","author":"Caughey","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2020.12.002_bib42","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0735-1097(03)00425-X","article-title":"Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE)","volume":"41","author":"Mozaffarian","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2020.12.002_bib43","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ehj.2004.04.023","article-title":"Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial","volume":"25","author":"Sharma","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2020.12.002_bib44","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jacc.2006.11.024","article-title":"Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial","volume":"49","author":"Ponikowski","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2020.12.002_bib45","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/eurjhf\/hfp130","article-title":"The safety and tolerability of darbepoetin alfa in patients with anaemia and symptomatic heart failure","volume":"11","author":"Klapholz","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hfc.2020.12.002_bib46","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ahj.2011.02.013","article-title":"Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials","volume":"161","author":"Kotecha","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2020.12.002_bib47","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/CIRCULATIONAHA.107.698514","article-title":"Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia","volume":"117","author":"Ghali","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2020.12.002_bib48","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of anemia with darbepoetin alfa in systolic heart failure","volume":"368","author":"Swedberg","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2020.12.002_bib49","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2020.12.002_bib50","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/ehf2.12797","article-title":"Anaemia, iron deficiency and heart failure in 2020","volume":"7","author":"Chopra","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hfc.2020.12.002_bib51","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial [published correction appears in JAMA 2017:317:2453]","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2020.12.002_bib52","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2020.12.002_bib53","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2020.12.002_bib54","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2020.12.002_bib55","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ejhf.473","article-title":"Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials","volume":"18","author":"Jankowska","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hfc.2020.12.002_bib56","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ejhf.823","article-title":"Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis","volume":"20","author":"Anker","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hfc.2020.12.002_bib57","doi-asserted-by":"crossref","first-page":"e004519","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","article-title":"Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients","volume":"11","author":"Grote Beverborg","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hfc.2020.12.002_bib58","doi-asserted-by":"crossref","first-page":"770","DOI":"10.7326\/0003-4819-159-11-201312030-00009","article-title":"Clinical guidelines committee of the American College of Physicians. treatment of anemia in patients with heart disease: a clinical practice guideline from the American College of Physicians [published correction appears in Ann Intern Med. 2014:160:144]","volume":"159","author":"Qaseem","year":"2013","journal-title":"Ann Intern Med"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713620300933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713620300933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:41:22Z","timestamp":1761554482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713620300933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1551713620300933"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2020.12.002","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anemia and Management of Heart Failure Patients","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2020.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}